An overview of the treatment options available for patients with renal cell carcinoma (RCC).
Role of Tivozanib in Renal Cell Carcinoma (RCC)
Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.
Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.
Dr Thomas Hutson shares his experience with tivozanib in his practice and ways to counsel patients regarding treatment options in the third-line setting.
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Trending on CURE
1
What the Art of Kintsugi Can Teach During a Cancer Journey
2
FDA Grants Orphan Drug Designation to MNV-201 for Myelodysplastic Syndrome
3
What Does Staging Mean in Liver Cancer?
4
What Breast Cancer Awareness Means to Me as a 23-Year Survivor
5
